SEC Form D filing

Gilgamesh Pharma Inc., 2026-02-04

An SEC Form D private-offering notice from New York, NY, a $6,090,946 filer-stated offering target in Biotech. Filed 2026-02-04. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Gilgamesh Pharma Inc. site↗ Verified via SEC Form D

Clinical stage biotech developing psychedelic and related novel chemical entities as treatments for psychiatric and neurological conditions

Filed 2026-02-04Filed to raise $6,090,946First money in 2026-01-02Raised so far $6,090,946HQ (as filed) New York, NYSector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified gilgameshpharmaceutical.com↗Named in the filing 6 executives & directors
Open this row on the live feed →More new filings in New York →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Also filed for this raise

every source Form D behind this opportunity
  • Gilgamesh Pharma Inc., 2026-02-04, $4.4M EDGAR↗
  • Gilgamesh Pharma Inc., 2026-02-04, $6.1M EDGAR↗

Other Form D filings from the same week

each with its own page and its own EDGAR source